Evotec
high unmet medical need no effective treatment | Evotec
Company
Deck Type
Sector
Industry
Deck date
November 2020
Slide
34 of 103
Related slides by other companies
Oculis
Investor Presentation
April 2024
high unmet need for novel treatments for efficacy onset tolerability | Oculis
AN2 Therapeutics
IPO
March 2022
phase part a phase pivotal clinical in treatment refractory mac lung disease not i laced confirmed anticipated trial design during meeting with activities underway phase part seamless enrollment | AN2 Therapeutics
Exscientia
Results
May 2022
the exalt trial i a be | Exscientia
Other recent decks by Evotec
See all presentations (5 decks)
Investor Presentation
March 2024
Investor Presentation
July 2022
ESG
February 2022
Results
August 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights